TY - JOUR
T1 - The efficacy of surgical shunts to treat severe portal hypertension after a Kasai procedure for biliary atresia
AU - Guérin, Florent
AU - Charre, Lionel
AU - Jasienski, Stéphanie
AU - Duché, Mathieu
AU - Franchiabella, Stéphanie
AU - Bernard, Olivier
AU - Jacquemin, Emmanuel
AU - Agostini, Hélène
AU - Gauthier, Frédéric
AU - Branchereau, Sophie
N1 - Publisher Copyright:
© 2018
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Background: To assess the outcome of patients with biliary atresia (BA) who underwent a surgical shunt (SS) for severe portal hypertension (PH) following a Kasai procedure. Methods: We collected and analyzed the data and outcomes of patients with BA who underwent SS for severe PH following a Kasai procedure between 1974 and 2014, focusing on complications related to the procedure, overall survival (OS), and transplant-free survival (TFS). Results: SS was performed at a median age of 5.5 years [2–13.5] in 38 patients. Conjugated bilirubin level (cBL) was ≤ 20 μmol/l in 24 patients at time of SS. Median follow-up was 15 years [1–32]. OS at 5 and 10 years was 91% and 87% respectively. TFS at 5 and 10 years was 84% and 70% respectively. Long-term complications included hepatic encephalopathy in 9 patients, and hepatopulmonary syndrome in 3. At last follow-up, 10/14 patients without LT and 18/ 24 who had a delayed LT at a median delay of 11 years [1.5–22] were alive. Conclusion: Surgical shunt for severe portal hypertension in biliary atresia may delay the need for liver transplantation. However complications are indications for transplantation. Level of evidence: Type of study: Therapeutic. Level of evidence III.
AB - Background: To assess the outcome of patients with biliary atresia (BA) who underwent a surgical shunt (SS) for severe portal hypertension (PH) following a Kasai procedure. Methods: We collected and analyzed the data and outcomes of patients with BA who underwent SS for severe PH following a Kasai procedure between 1974 and 2014, focusing on complications related to the procedure, overall survival (OS), and transplant-free survival (TFS). Results: SS was performed at a median age of 5.5 years [2–13.5] in 38 patients. Conjugated bilirubin level (cBL) was ≤ 20 μmol/l in 24 patients at time of SS. Median follow-up was 15 years [1–32]. OS at 5 and 10 years was 91% and 87% respectively. TFS at 5 and 10 years was 84% and 70% respectively. Long-term complications included hepatic encephalopathy in 9 patients, and hepatopulmonary syndrome in 3. At last follow-up, 10/14 patients without LT and 18/ 24 who had a delayed LT at a median delay of 11 years [1.5–22] were alive. Conclusion: Surgical shunt for severe portal hypertension in biliary atresia may delay the need for liver transplantation. However complications are indications for transplantation. Level of evidence: Type of study: Therapeutic. Level of evidence III.
KW - Biliary atresia
KW - Kasai
KW - Portal hypertension
KW - Portosystemic shunt
UR - http://www.scopus.com/inward/record.url?scp=85049444430&partnerID=8YFLogxK
U2 - 10.1016/j.jpedsurg.2018.06.023
DO - 10.1016/j.jpedsurg.2018.06.023
M3 - Article
C2 - 29983186
AN - SCOPUS:85049444430
SN - 0022-3468
VL - 54
SP - 531
EP - 536
JO - Journal of Pediatric Surgery
JF - Journal of Pediatric Surgery
IS - 3
ER -